Literature DB >> 29152673

Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM).

E Sbardella1, A M Isidori1, G Arnaldi2, M Arosio3, C Barone4, A Benso5, R Berardi6, G Capasso7, M Caprio8,9, F Ceccato10, G Corona11, S Della Casa12, L De Nicola13, M Faustini-Fustini14, E Fiaccadori15, L Gesualdo16, S Gori17, A Lania18, G Mantovani3, P Menè19, G Parenti20, C Pinto21, R Pivonello22, P Razzore23, G Regolisti15, C Scaroni10, F Trepiccione7, A Lenzi1, A Peri24.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 29152673     DOI: 10.1007/s40618-017-0776-x

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  133 in total

1.  Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial.

Authors:  Alexander L Gerbes; Veit Gülberg; Pere Ginès; Guy Decaux; Peter Gross; Hassan Gandjini; Jacques Djian
Journal:  Gastroenterology       Date:  2003-04       Impact factor: 22.682

2.  A Retrospective Analysis of Risk Factors for Linezolid-Associated Hyponatremia in Japanese Patients.

Authors:  Ryota Tanaka; Yosuke Suzuki; Yukie Takumi; Motoshi Iwao; Yuhki Sato; Kazuhiko Hashinaga; Kazufumi Hiramatsu; Jun-Ichi Kadota; Hiroki Itoh
Journal:  Biol Pharm Bull       Date:  2016       Impact factor: 2.233

3.  Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE study.

Authors:  Antoine Roquilly; Pierre Joachim Mahe; Philippe Seguin; Christophe Guitton; Hervé Floch; Anne Charlotte Tellier; Laurent Merson; Benoît Renard; Yannick Malledant; Laurent Flet; Véronique Sebille; Christelle Volteau; Damien Masson; Jean Michel Nguyen; Corinne Lejus; Karim Asehnoune
Journal:  JAMA       Date:  2011-03-23       Impact factor: 56.272

4.  Mild hyponatremia as a risk factor for fractures: the Rotterdam Study.

Authors:  Ewout J Hoorn; Fernando Rivadeneira; Joyce B J van Meurs; Gijsbertus Ziere; Bruno H Ch Stricker; Albert Hofman; Huibert A P Pols; Robert Zietse; André G Uitterlinden; M Carola Zillikens
Journal:  J Bone Miner Res       Date:  2011-08       Impact factor: 6.741

5.  Hyponatremia in the outpatient setting: clinical characteristics, risk factors, and outcome.

Authors:  Vildan Tasdemir; Ali Kemal Oguz; Irmak Sayın; Ihsan Ergun
Journal:  Int Urol Nephrol       Date:  2015-10-22       Impact factor: 2.370

6.  Hyponatremia, mineral metabolism, and mortality in incident maintenance hemodialysis patients: a cohort study.

Authors:  Sagar U Nigwekar; Julia Wenger; Ravi Thadhani; Ishir Bhan
Journal:  Am J Kidney Dis       Date:  2013-04-13       Impact factor: 8.860

Review 7.  Tumor-related hyponatremia.

Authors:  Adedayo A Onitilo; Ebenezer Kio; Suhail A R Doi
Journal:  Clin Med Res       Date:  2007-12-17

8.  Treatment of euvolemic hyponatremia in the intensive care unit by urea.

Authors:  Guy Decaux; Caroline Andres; Fabrice Gankam Kengne; Alain Soupart
Journal:  Crit Care       Date:  2010-10-14       Impact factor: 9.097

9.  Hyponatremia improvement is associated with a reduced risk of mortality: evidence from a meta-analysis.

Authors:  Giovanni Corona; Corinna Giuliani; Joseph G Verbalis; Gianni Forti; Mario Maggi; Alessandro Peri
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

10.  Mild hyponatremia, hypernatremia and incident cardiovascular disease and mortality in older men: A population-based cohort study.

Authors:  S G Wannamethee; A G Shaper; L Lennon; O Papacosta; P Whincup
Journal:  Nutr Metab Cardiovasc Dis       Date:  2015-08-05       Impact factor: 4.222

View more
  6 in total

Review 1.  When kidneys and lungs suffer together.

Authors:  Claudio Sorino; Nicola Scichilone; Claudio Pedone; Stefano Negri; Dina Visca; Antonio Spanevello
Journal:  J Nephrol       Date:  2018-12-06       Impact factor: 3.902

2.  Sodium alterations impair the prognosis of hospitalized patients with COVID-19 pneumonia.

Authors:  Marianna Martino; Paolo Falcioni; Giulia Giancola; Alessandro Ciarloni; Gianmaria Salvio; Francesca Silvetti; Augusto Taccaliti; Giorgio Arnaldi
Journal:  Endocr Connect       Date:  2021-10-15       Impact factor: 3.335

Review 3.  Sleep Disorders in Patients With Craniopharyngioma: A Physiopathological and Practical Update.

Authors:  Andrea Romigi; Tiziana Feola; Simone Cappellano; Michelangelo De Angelis; Giacomo Pio; Marco Caccamo; Federica Testa; Giuseppe Vitrani; Diego Centonze; Claudio Colonnese; Vincenzo Esposito; Marie-Lise Jaffrain-Rea
Journal:  Front Neurol       Date:  2022-02-09       Impact factor: 4.003

4.  Effect of vasopressin V2-receptor antagonist tolvaptan on syndrome of inappropriate antidiuresis (SIAD) after transsphenoidal pituitary surgery: recovery of measured osmolality.

Authors:  Masahiko Tosaka; Rei Yamaguchi; Yutaro Itabashi; Naoto Mukada; Haruka Tsuneoka; Kentaro Takahashi; Shunsuke Nakamura; Takahiko Nakazawa; Yuhei Yoshimoto
Journal:  Heliyon       Date:  2022-10-05

5.  Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis.

Authors:  Rita Indirli; Júlia Ferreira de Carvalho; Arianna Cremaschi; Beatrice Mantovani; Elisa Sala; Andreea Liliana Serban; Marco Locatelli; Giulio Bertani; Giulia Carosi; Giorgio Fiore; Leonardo Tariciotti; Maura Arosio; Giovanna Mantovani; Emanuele Ferrante
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-24       Impact factor: 5.555

6.  Serum sodium alterations in SARS CoV-2 (COVID-19) infection: impact on patient outcome.

Authors:  Andrea Berni; Danilo Malandrino; Giovanni Corona; Mario Maggi; Gabriele Parenti; Benedetta Fibbi; Loredana Poggesi; Alessandro Bartoloni; Federico Lavorini; Andrea Fanelli; Giulia Scocchera; Carlo Nozzoli; Adriano Peris; Filippo Pieralli; Riccardo Pini; Andrea Ungar; Alessandro Peri
Journal:  Eur J Endocrinol       Date:  2021-05-28       Impact factor: 6.558

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.